Understanding how proteins interact with RNA in editing processes
Defining and Controlling Protein-RNA interactions in editing and interference pathways
This study is looking at how certain proteins change RNA, which could help us understand and find new treatments for conditions like Aicardi-Goutieres Syndrome and some cancers, so patients might benefit from better options in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11112312 on NIH RePORTER |
What this research studies
This research focuses on the interactions between proteins and RNA, specifically looking at how certain enzymes can modify RNA sequences. By studying the ADAR enzymes, which convert adenosines to inosines in RNA, the research aims to uncover the structural details of these interactions and their implications for diseases like Aicardi-Goutieres Syndrome and certain cancers. The project will explore how these modifications affect RNA function and how they can potentially be used to correct genetic mutations. Patients may benefit from insights that could lead to new treatments for autoimmune diseases and cancers linked to RNA editing.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with autoimmune diseases such as Aicardi-Goutieres Syndrome or those affected by conditions related to RNA editing.
Not a fit: Patients with unrelated genetic disorders or those not affected by autoimmune diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating autoimmune diseases and certain cancers.
How similar studies have performed: Previous research has shown promise in understanding RNA editing mechanisms, suggesting that this approach could yield significant insights.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Beal, Peter a. — University of California at Davis
- Study coordinator: Beal, Peter a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.